OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

Director received an award of 106.19 AMGN shares | OQRO

Home
Insider trades
Amgen
Director received an award of 106.19 AMGN shares

Insider trades

Insider trade

Director received an award of 106.19 AMGN shares

Traded May 5, 2026 · Filed May 8, 2026

AmgenAMGN

106.19
Shares

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: May 5, 2026
Reporting period: Not applicable
Filed with the SEC: May 8, 2026

DirectorGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references dividend reinvestment

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0000318154-26-000071
Filed / recorded

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

May 8, 2026, 12:40 AM UTC

Added to OQRO

Oct 2, 2026, 12:27 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

AMGEN INC

Issuer CIK

318154

Ticker

AMGN

Reporting person

Omar Ishrak

Relationship

Director

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

May 5, 2026

Transaction code

Shares / units

106.1925

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

6,693.7361

Ownership form

Direct

Amendment

Footnotes from the filing

These shares include 418 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.